SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-25-001010 to Clene Inc. (CLNN)

Clene Inc.
Date: Jan. 30, 2025 · CIK: 0001822791 · Accession: 0000000000-25-001010

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-284479

Date
January 30, 2025
Author
Robert Etherington
Form
UPLOAD
Company
Clene Inc.

Letter

January 30, 2025 Robert Etherington Chief Executive Officer Clene Inc. 6550 South Millrock Drive, Suite G50 Salt Lake City, UT 84121 Re:Clene Inc. Registration Statement on Form S-3 Filed January 24, 2025 File No. 333-284479 Dear Robert Etherington: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tyler Howes at 202-551-3370 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Tom McAleavey, Esq,

Show Raw Text
January 30, 2025
Robert Etherington
Chief Executive Officer
Clene Inc.
6550 South Millrock Drive, Suite G50
Salt Lake City, UT 84121
Re:Clene Inc.
Registration Statement on Form S-3
Filed January 24, 2025
File No. 333-284479
Dear Robert Etherington:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Tyler Howes at 202-551-3370 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Tom McAleavey, Esq,